Alnylam Pharmaceuticals, Inc. (ALNY)
286.98
-6.47
(-2.20%)
USD |
NASDAQ |
May 15, 16:00
286.73
-0.25
(-0.09%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price : 286.98 for May 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Aldeyra Therapeutics, Inc. | 1.68 |
| Ionis Pharmaceuticals, Inc. | 74.23 |
| Gilead Sciences, Inc. | 129.58 |
| Regeneron Pharmaceuticals, Inc. | 698.25 |
| Sarepta Therapeutics, Inc. | 17.55 |
Price Related Metrics
| PE Ratio | 68.19 |
| PS Ratio | 9.079 |
| Price to Book Value | 35.63 |
| Price to Free Cash Flow | 60.69 |
| Earnings Yield | 1.47% |
| Market Cap | 38.32B |
| Operating PE Ratio | 51.75 |
| Normalized PE Ratio | 69.59 |